Sandostatin and Renal failure acute - a phase IV clinical study of FDA data
Renal failure acute is found among people who take Sandostatin, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Sandostatin and have Renal failure acute. It is created by eHealthMe based on reports of 42,695 people who have side effects when taking Sandostatin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
42,695 people reported to have side effects when taking Sandostatin.
Among them, 98 people (0.23%) have Renal failure acute.
What is Sandostatin?
Sandostatin has active ingredients of octreotide acetate. It is often used in acromegaly. eHealthMe is studying from 42,795 Sandostatin users for its effectiveness, alternative drugs and more.
What is Renal failure acute?
Renal failure acute (rapid kidney dysfunction) is found to be associated with 3,078 drugs and 3,072 conditions by eHealthMe.
Number of Sandostatin and Renal failure acute reports submitted per year:
Time on Sandostatin when people have Renal failure acute *:
- < 1 month: 54.17 %
- 1 - 6 months: 12.5 %
- 6 - 12 months: 8.33 %
- 1 - 2 years: 8.33 %
- 2 - 5 years: 8.33 %
- 5 - 10 years: 8.33 %
- 10+ years: 0.0 %
Gender of people who have Renal failure acute when taking Sandostatin *:
- female: 56.25 %
- male: 43.75 %
Age of people who have Renal failure acute when taking Sandostatin *:
- 0-1: 1.23 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 1.23 %
- 30-39: 7.41 %
- 40-49: 1.23 %
- 50-59: 11.11 %
- 60+: 77.78 %
Common drugs people take besides Sandostatin *:
- Lomotil: 15 people, 15.31%
- Digoxin: 11 people, 11.22%
- Lansoprazole: 9 people, 9.18%
- Protonix: 9 people, 9.18%
- Questran: 9 people, 9.18%
- Lasix: 9 people, 9.18%
- Zofran: 9 people, 9.18%
- Ms Contin: 8 people, 8.16%
- Oxycontin: 8 people, 8.16%
- Synthroid: 8 people, 8.16%
Common side effects people have besides Renal failure acute *:
- Diarrhea: 50 people, 51.02%
- Dehydration (dryness resulting from the removal of water): 30 people, 30.61%
- Blood Creatinine Increased: 30 people, 30.61%
- Hyperkalemia (damage to or disease of the kidney): 25 people, 25.51%
- Nausea And Vomiting: 22 people, 22.45%
- Abdominal Pain: 17 people, 17.35%
- Haemoglobin Decreased: 16 people, 16.33%
- Drug Ineffective: 16 people, 16.33%
- Anaemia (lack of blood): 16 people, 16.33%
- Hypotension (abnormally low blood pressure): 16 people, 16.33%
Common conditions people have *:
- Vipoma (endocrine tumour): 16 people, 16.33%
- High Blood Pressure: 12 people, 12.24%
- Diarrhea: 8 people, 8.16%
- Neuroendocrine Tumor: 5 people, 5.10%
- Anaemia (lack of blood): 5 people, 5.10%
- Diabetes: 5 people, 5.10%
- Abdominal Pain: 5 people, 5.10%
- Enlarged Prostate: 4 people, 4.08%
- Tongue Oedema (swelling of tongue): 4 people, 4.08%
- Indigestion: 4 people, 4.08%
* Approximation only. Some reports may have incomplete information.
Do you take Sandostatin and have Renal failure acute?Check whether Renal failure acute is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Saif MW, "Rheumatoid arthritis associated with the use of Sandostatin? LAR? depot in a patient with pancreatic neuroendocrine tumor", An association or a coincidence? The first case report, 2017 Jan .
- Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
- Azkur D, Yoldas T, Toyran M, Kocabas CN, "A pediatric case of anaphylaxis due to octreotide", Asian Pacific journal of allergy and immunology, 2011 Dec .
How severe was Renal failure acute and when was it recovered:
Expand to all the drugs that have ingredients of octreotide acetate:
Alternative drugs to, pros and cons of Sandostatin:
- Sandostatin (42,795 reports)
Common Sandostatin side effects:
- Diarrhea: 9,954 reports
- High blood pressure: 9,507 reports
- Fatigue (feeling of tiredness): 8,310 reports
- Pain: 5,987 reports
- Weakness: 5,807 reports
Browse all side effects of Sandostatin:a b c d e f g h i j k l m n o p q r s t u v w x y z
Renal failure acute treatments and more:
- Renal failure acute (73,864 reports)
COVID vaccines that are related to Renal failure acute:
- Renal failure acute in Moderna COVID Vaccine
- Renal failure acute in Pfizer BioNTech Covid Vaccine
- Renal failure acute in Johnson and Johnson Covid Vaccine
Common drugs associated with Renal failure acute:
- Metformin: 5,929 reports
- Aspirin: 5,823 reports
- Lasix: 5,489 reports
- Furosemide: 5,462 reports
- Lisinopril: 4,178 reports
- Simvastatin: 3,559 reports
- Omeprazole: 3,429 reports
- Prednisone: 3,314 reports
- Allopurinol: 3,241 reports
- Lopurin: 3,241 reports
All the drugs that are associated with Renal failure acute:
- Renal failure acute (3,078 drugs)
Common conditions associated with Renal failure acute:
- High blood pressure: 6,913 reports
- Type 2 diabetes: 3,046 reports
- Diabetes: 2,594 reports
- Pain: 2,373 reports
- Atrial fibrillation/flutter: 2,264 reports
- Multiple myeloma: 1,881 reports
All the conditions that are associated with Renal failure acute:
- Renal failure acute (3,072 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on octreotide acetate (the active ingredients of Sandostatin) and Sandostatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hexalen and Incontinence - 17 seconds ago
- Desloratadine and Sinus Tachycardia - 56 seconds ago
- Sinequan and Atherosclerosis - a minute ago
- Avelox and Sleep Walking - a minute ago
- Hepatobiliary Scan Abnormal and Skin Blushing/Flushing - 2 minutes ago
- Morphine and Breathing Sounds - Abnormal (Stridor) - 2 minutes ago
- Rashes and Peripheral Coldness - 2 minutes ago
- Cyanocobalamin and Epidiolex drug interaction - 3 minutes ago
- Alprazolam and Cervical Spinal Stenosis - 3 minutes ago
- Alphagan and Ejaculation Failure - 4 minutes ago